Itsuki Anzai
Impact in
- Neurology top 10%
- Amyotrophic Lateral Sclerosis Research
- Parkinson's Disease Mechanisms and Treatments
Papers in
-
- Amyotrophic Lateral Sclerosis Research 6
- Parkinson's Disease Mechanisms and Treatments 3
-
- SARS-CoV-2 and COVID-19 Research 5
- COVID-19 Clinical Research Studies 2
- Co-authors
- Yoshiaki Furukawa (6 shared papers)Shuji Akiyama (4 shared papers)Yoshiharu Matsuura (8 shared papers)Eiichi Tokuda (4 shared papers)Chikako Ono (6 shared papers)Yusuke Maeda (2 shared papers)Takasuke Fukuhara (3 shared papers)Yuzy Fauzyah (3 shared papers)
In The Last Decade
Itsuki Anzai
17 papers receiving 336 citations
Peers
Comparison fields: 5 of 75
- Neurology 109
- Structural Biology 10
- Infectious Diseases 103
- Genetics 30
- Animal Science and Zoology 30
Countries citing papers authored by Itsuki Anzai
This map shows the geographic impact of Itsuki Anzai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Itsuki Anzai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Itsuki Anzai more than expected).
Fields of papers citing papers by Itsuki Anzai
This network shows the impact of papers produced by Itsuki Anzai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Itsuki Anzai. The network helps show where Itsuki Anzai may publish in the future.
Co-authors
The 25 scholars most cited alongside Itsuki Anzai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 102 | |
| 2 | 2015 | 40 | |
| 3 | 2016 | 35 | |
| 4 | 2016 | 21 | |
| 5 | 2017 | 20 | |
| 6 | 2019 | 20 | |
| 7 | 2021 | 19 | |
| 8 | 2014 | 17 | |
| 9 | 2020 | 15 | |
| 10 | 2023 | 15 | |
| 11 | 2023 | 8 | |
| 12 | 2022 | 7 | |
| 13 | 2022 | 7 | |
| 14 | 2024 | 7 | |
| 15 | 2024 | 2 | |
| 16 | 2022 | 2 | |
| 17 | 2022 | 1 | |
| 18 | 2026 | 0 |
About Itsuki Anzai
Itsuki Anzai is a scholar working on Neurology, Infectious Diseases, Molecular Biology, Pharmacology and Genetics, having authored 18 papers that have together received 338 indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Parkinson's Disease Mechanisms and Treatments (3 papers), Neurogenetic and Muscular Disorders Research (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Seaweed-derived Bioactive Compounds (2 papers), biodegradable polymer synthesis and properties (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Neurology (109 citations), Structural Biology (10 citations), Infectious Diseases (103 citations), Genetics (30 citations) and Animal Science and Zoology (30 citations). Itsuki Anzai has collaborated with scholars based in Japan and France. Frequent co-authors include Yoshiaki Furukawa, Shuji Akiyama, Yoshiharu Matsuura, Eiichi Tokuda, Chikako Ono, Yusuke Maeda, Takasuke Fukuhara, Yuzy Fauzyah, Shiho Torii and Rigel Suzuki. Their work appears in journals such as Scientific Reports, Journal of Biological Chemistry, iScience, Cell Reports and The Journal of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.